Arsenal Capital Partners, a leading specialized private equity firm investing in specialty industrials and healthcare companies, announced today the addition of Michael Bernstein to its healthcare team.
Caprion Biosciences and HistoGeneX announced today they have agreed to combine their respective businesses. The new partnership creates a global leader in immune monitoring, protein characterization, and tissue pathology solutions for immunotherapy and drug development.
Accumen Inc. has acquired Halfpenny Technologies Inc., a Pennsylvania-based leader in data performance through its industry-leading clinical data exchange and business intelligence solutions providing secure, scalable, cloud-based, vendor-neutral, clinical data exchange platforms to health systems, commercial labs, health plans, and other channel partners throughout the industry. This is the first acquisition for Accumen since it was acquired by Arsenal in January.
Arsenal announced today the acquisition of Accumen Inc., a leading technology-enabled provider of health system performance optimization solutions, from Accretive, LLC, a specialized investment firm based in New York.
Arsenal Capital Partners is a specialized private equity firm with a deep focus in two sectors, Specialty Industrials and Healthcare. Our philosophy is to partner with talented management teams, provide them with access to world-class operating resources and patient capital, and develop positive, open and constructive relationships that foster long-term value creation.